How to report toxicity associated with targeted therapies?
Cabarrou, B., Boher, J.M., Bogart, E., Tresch-Bruneel, E., Penel, N., Ravaud, A., Escudier, B., Mahier Ait-Oukhatar, C., Delord, J.P., Roché, H., Filleron, T.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma
Blay, J.Y., Cropet, C., Mansard, S., Loriot, Y., De La Fouchardière, C., Haroche, J., Topart, D., Tougeron, D., You, B., Italiano, A., Le Brun-Ly, V., Ferrero, J.M., Penel, N., Fabbro, M., Troussard, X., Malka, D., Ray-Coquard, I., Leboulleux, S., Fléchon, A., Maubec, E., Charles, J., Dalle, S., Taieb, S., Garcia, G.C.T.E., Mandache, A.M., Colignon, N., Gavrel, M., Nowak, F., Hoog Labouret, N., Mahier Aït Oukhatar, C., Gomez-Roca, C.
Published in ESMO open (01.12.2023)
Published in ESMO open (01.12.2023)
Get full text
Journal Article
Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial
Pierga, J.-Y., Bidard, F.-C., Cropet, C., Tresca, P., Dalenc, F., Romieu, G., Campone, M., Mahier Aït-Oukhatar, C., Le Rhun, E., Gonçalves, A., Leheurteur, M., Dômont, J., Gutierrez, M., Curé, H., Ferrero, J.-M., Labbe-Devilliers, C., Bachelot, T.
Published in Annals of oncology (01.12.2013)
Published in Annals of oncology (01.12.2013)
Get full text
Journal Article
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2
Brain, E, Isambert, N, Dalenc, F, Diéras, V, Bonneterre, J, Rezai, K, Jimenez, M, Mefti-Lacheraf, F, Cottura, E, Tresca, P, Vanlemmens, L, Mahier-Aït Oukhatar, C, Lokiec, F, Fumoleau, P
Published in British journal of cancer (14.02.2012)
Published in British journal of cancer (14.02.2012)
Get full text
Journal Article
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
Mazieres, J., Cropet, C., Montané, L., Barlesi, F., Souquet, P.J., Quantin, X., Dubos-Arvis, C., Otto, J., Favier, L., Avrillon, V., Cadranel, J., Moro-Sibilot, D., Monnet, I., Westeel, V., Le Treut, J., Brain, E., Trédaniel, J., Jaffro, M., Collot, S., Ferretti, G.R., Tiffon, C., Mahier-Ait Oukhatar, C., Blay, J.Y.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
Vemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial
Mazières, J., Montané, L., Barlesi, F., Quantin, X., Trédaniel, J., Le Treut, J., Avrillon, V., Lavolé, A., Westeel, V., Orsini Piocelle, F., Pichon, E., Thiberville, L., Borel, C., Renault, P.A., Jaffro, M., Collot, S., Ferretti, G., Legrand, F., Mahier Ait Oukhatar, C., Blay, J.Y.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé program
Vassal, G, Cozic, N, Houot, R, Brugières, L, Aparicio, T, Blay, J-Y, Perol, M, Brice, P, Meriaux, E, Geoerger, B, El Bejjani, M R, Moalla, S, Bièche, I, Lantuejoul, S, Mahier Ait Oukhatar, C, Hoog Labouret, N, Moro-Sibilot, D
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
MO-0872 Circulating tumor cells and efficacy of prostate bed salvage radiotherapy combined with abiraterone
Supiot, S., Ah-Thiane, L., Campion, L., Allouache, N., Meyer, E., Pommier, P., Carrie, C., Mesgouez-Nebout, N., Créhange, G., Guimas, V., Rio, E., Sargos, P., MAHIER AIT OUKHATAR, C.
Published in Radiotherapy and oncology (01.05.2023)
Published in Radiotherapy and oncology (01.05.2023)
Get full text
Journal Article
260P Antitumor activity of trastuzumab deruxtecan (T-DXd) in patients with metastatic breast cancer (mBC) and brain metastases (BMs) from DAISY trial
Epaillard, N., Lusque, A., Pistilli, B., André, F., Bachelot, T., Pierga, J-Y., Ducoulombier, A., Jouannaud, C., Viret, F., Salabert, L., Johnson, A.C., Deluche, E., Durando, X., Petit, T., Filleron, T., Mahier Ait Oukhatar, C., Dieras, V.C., Mosele, M.F.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large cell lymphoma in children, adolescents and adult patients: results of the French AcSe-crizotinib trial
Brugières, L, Cozic, N, Houot, R, Rigaud, C, Sibon, D, Arfi-Rouche, J, Bories, P, Cottereau, AS, Delmer, A, Ducassou, S, Garnier, N, Lamant, L, Leruste, A, Millot, F, Moalla, S, Morschhauser, F, Nolla, M, Pagnier, A, Reguerre, Y, Renaud, L, Schmitt, A, Simonin, M, Verschuur, A, Hoog Labouret, N, Mahier Ait Oukhatar, C, Vassal, G
Published in European journal of cancer (1990) (01.09.2023)
Published in European journal of cancer (1990) (01.09.2023)
Get full text
Journal Article
434PBiomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé program
Vassal, G, Cozic, N, Houot, R, Brugières, L, Aparicio, T, Blay, J-Y, Perol, M, Brice, P, Meriaux, E, Geoerger, B, El Bejjani, M R, Moalla, S, Bièche, I, Lantuejoul, S, Mahier Ait Oukhatar, C, Hoog Labouret, N, Moro-Sibilot, D
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1488PVemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial
Mazières, J, Montané, L, Barlesi, F, Quantin, X, Trédaniel, J, Le Treut, J, Avrillon, V, Lavolé, A, Westeel, V, Orsini Piocelle, F, Pichon, E, Thiberville, L, Borel, C, Renault, P A, Jaffro, M, Collot, S, Ferretti, G, Legrand, F, Mahier Ait Oukhatar, C, Blay, J Y
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
7P Trastuzumab deruxtecan (T-DXd) for advanced breast cancer (ABC) patients (pts), regardless of HER2 status: A phase II study with biomarkers analysis (DAISY) - update analysis with longer follow-up
Dieras, V.C., André, F., Lusque, A., Pistilli, B., Bachelot, T., Pierga, J-Y., Viret, F., Levy, C., Salabert, L., Dalenc, F., Jouannaud, C., Fournel, P., Durando, X., Petit, T., Ait Oukhatar, C. Mahier, Filleron, T., Mosele, M.F., Lacroix-Triki, M., Ducoulombier, A., Deluche, E.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial
Mazieres, J., Montané, L., Barlesi, F., Coudert, B., Souquet, P.J., Otto, J., Gervais, R., Moro-Sibilot, D., Monnet, I., Brain, E., Huillard, O., Quéré, G., Debieuvre, D., Fabre, E., Jaffro, M., Collot, S., Ferretti, G., Tiffon, C., Mahier - Ait Oukhatar, C., Blay, J.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
OA12.03 Activity of Crizotinib in MET or ROS1 Positive (+) NSCLC: Results of the AcSé Trial
Moro-Sibilot, D., Cozic, N., Pérol, M., Otto, J., Mazieres, J., Souquet, P., Bahleda, R., Wislez, M., De Guibert, S., Mennecier, B., Chouaid, C., Sabatier, R., Bota, S., Gervais, R., Verriele, V., Haddad, V., Ferretti, G., Nowak, F., Mahier - Ait Oukhatar, C., Vassal, G.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
Lower risk of cutaneous squamous cell carcinomas induced by vemurafenib in non melanoma patients
Maubec, E., Levy, A., Cropet, C., Mazieres, J., Troussard, X., Leboulleux, S., Malka, D., Dinulescu, M., Granel-Brocard, F., Le Goupil, D., Truchetet, F., Dalle, S., Leccia, M.T., Hoog-Labouret, N., Oukhatar, C. Mahier Ait, Busser, B., Charles, J., Blay, J.-Y.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Vemurafenib in non-small-cell lung cancer patients with BRAF V600 and BRAF nonV600 mutations
Mazieres, J, Cropet, C, Montané, L, Barlesi, F, Souquet, P J, Quantin, X, Dubos-Arvis, C, Otto, J, Favier, L, Avrillon, V, Cadranel, J, Moro-Sibilot, D, Monnet, I, Westeel, V, Le Treut, J, Brain, E, Trédaniel, J, Jaffro, M, Collot, S, Ferretti, G R, Tiffon, C, Mahier-Ait Oukhatar, C, Blay, J Y
Published in Annals of oncology (01.02.2020)
Get full text
Published in Annals of oncology (01.02.2020)
Journal Article
MA21.07 Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
Ortiz-Cuaran, S., Mezquita, L., Swalduz, A., Aldea, M., Mazieres, J., Jovelet, C., Flores, W.R. Chumbi, Lacroix, L., Loriot, Y., Friboulet, L., Westeel, V., Ngocamus, M., Pradines, A., Tissot, C., Duchene, C. Clement, Raynaud, C., Quantin, X., Gervais, R., Brain, E., Monnet, I., Leprieur, E. Giroux, Avrillon, V., Mahier-Aït Oukhatar, C., Hoog-Labouret, N., De Kievit, F., Howarth, K., Guichou, J., Morris, C., Green, E., Perol, M., Besse, B., Blay, J., Saintigny, P., Planchard, D.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF V600 -mutated melanoma
Blay, J Y, Cropet, C, Mansard, S, Loriot, Y, De La Fouchardière, C, Haroche, J, Topart, D, Tougeron, D, You, B, Italiano, A, Le Brun-Ly, V, Ferrero, J M, Penel, N, Fabbro, M, Troussard, X, Malka, D, Ray-Coquard, I, Leboulleux, S, Fléchon, A, Maubec, E, Charles, J, Dalle, S, Taieb, S, Garcia, G C T E, Mandache, A M, Colignon, N, Gavrel, M, Nowak, F, Hoog Labouret, N, Mahier Aït Oukhatar, C, Gomez-Roca, C
Published in ESMO open (01.12.2023)
Get full text
Published in ESMO open (01.12.2023)
Journal Article
Abstract P3-12-01: Serum biomarkers identification using quantitative proteomics in patients (pts) with untreated brain metastases from HER2-positive breast cancer receiving capecitabine (C) and lapatinib (L) (UNICANCER LANDsCAPE trial)
Gonçalves, A, Camoin, L, Ben, Younès I, Romieu, G, Campone, M, Diéras, V, Cropet, C, Mahier, Aït-Oukhatar C, Dalenc, F, Le, Rhun E, Labbe-Devilliers, C, Borg, J-P, Bachelot, T
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article